Tocagen, Inc. (Tocagen)

Oncology Corporate Profile

HQ Location

3030 Bunker Hill St. Suite 230
San Diego, CA 92109

Company Description

Tocagen Inc. is a privately funded, clinical stage biopharmaceutical company pursuing the discovery, development and commercialization of gene therapy products for the selective treatment of cancer. Tocagen is initially focusing on treatments for patients with advanced cancer for whom no adequate treatments currently exist.

Website: http://www.tocagen.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
Toca 511 (+ Toca FC)retroviral replicating vectorBrain Metastases from Breast cancerPreclinical
Toca 511 (+ Toca FC)retroviral replicating vectorBrain Metastases from Non-Small Cell Lung Cancer (NSCLC)Preclinical
Toca 511 (+ Toca FC)retroviral replicating vectorColorectal cancerPreclinical
Toca 511 (+ Toca FC)retroviral replicating vectorGlioblastoma Multiforme (GBM)Preclinical
Toca 511 (+ Toca FC)retroviral replicating vectorMelanomaPreclinical
Toca 511 (+ Toca FC)retroviral replicating vectorRenal cell carcinoma (RCC)Preclinical

View additional information on product candidates here »

Source: http://www.tocagen.com

Recent News Headlines

There are no news items to display